SUPPORT+ Digital Self-Management and Clinical Support for Patients With Advanced Cancer in the Community: A Randomized Controlled Trial
Sponsor: The University of Hong Kong
Trial Details
| Condition | Palliative Care, Advanced Cancer |
| Intervention | SUPPORT+ Digital Symptom Monitoring and Clinical Support |
| Phase | NA |
| Status | Active |
| Participants | 633 |
| Est. Completion | 31 Dec 2026 |
| Last Updated | 2 Apr 2026 |
Primary Outcome
Change in Health-Related Quality of Life (EQ-5D-5L index); Change in Self-rated health measured by EQ-VAS
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Adults aged 18 years or older * Diagnosis of advanced malignancy * Decision not to pursue further systemic anticancer treatment * Receiving follow-up care at a participating palliative care clinic * Community-dwelling * Ownership of a smartphone * Adequate cognitive capacity to provide informed consent * Willingness to receive notifications from the SUPPORT+ mobile application * Presence of at least one symptom related to advanced cancer * Ability for the patient or a designated primary caregiver to use the mobile application Exclusion Criteria: * Receiving systemic anticancer therapy with radical or palliative intent * Estimated life expectancy of less than 3 months * Eastern Cooperative Oncology Group (ECOG) performance status greater than 3
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service